USSTOCK.TODAY
Regular Market
Log in Sign up

ResMed Q1 FY2027 Revenue Grows 7% and Returns Over $1 Billion to Shareholders

The Motley Fool +1 · ·by G4L

RMD Resmed Inc
$235.30 -1.68%
View chart & analysis →
  1. 1ResMed recorded 7% growth in core constant currency revenue for the first quarter of fiscal year 2027.
  2. 2ResMed returned over $1 billion to shareholders through share buybacks and dividends during the quarter.
  3. 3Non-GAAP EPS grew 14%.

So what's the key point?

ResMed's revenue grew by 7%. The company returned more than $1 billion to its shareholders.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Required Minimum Distribution (RMD) rules for tax-deferred retirement accounts The Motley Fool +1 · Oct 27ResMed Inc shares rise ahead of earnings as FY2027 growth outlook is lowered Earnings Whispers · Oct 22Under Armour cuts FY27 revenue outlook on weak demand Medical Device Network +2 · Aug 10
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news